Mitani Medical Transcription is categorized under Secretarial Services in Costa Mesa, CA and active since 1996.
Mitani Medical Transcription was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Secretarial Services business, which does work in the B2B market, and is classified as a Secretarial Services, under code number 5614920 by the NAICS.
If you are seeking more information, feel free to contact Barbara Mitani, Owner at the company’s single location by writing to 3075 Roanoke Lane, Costa Mesa, California CA 92626 or by phoning (714) 957-3100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mitani Medical Transcription |
| Contact Person: | Barbara Mitani, Owner |
| Address: | 3075 Roanoke Lane, Costa Mesa, California 92626 |
| Phone Number: | (714) 957-3100 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Secretarial Services |
| SIC Code: | 7338 |
| NAICS Code: | 5614920 |
| Share This Business: |
Mitani Medical Transcription was started in 1996 to provide professional Secretarial Services under the SIC code 7338 and NAICS code 5614920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Barbara Mitani, Owner for inquiries that concern Mitani Medical Transcription by calling the company number (714) 957-3100, as your correspondence is most welcome. Additionally, the physical location of the single location of Mitani Medical Transcription can be found at the coordinates 33.683182,-117.889204 as well as the street address 3075 Roanoke Lane in Costa Mesa, California 92626.
For its online presence, you may visit Mitani Medical Transcription’s website at and engage with its social media outlets through on Twitter and on Facebook.